{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:04:17Z","timestamp":1787162657289,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Johns Hopkins University School of Medicine"},{"name":"Neurofibromatosis Therapeutic Acceleration Program"},{"DOI":"10.13039\/501100004837","name":"Spanish Ministry of Science and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI14\/00577"],"award-info":[{"award-number":["PI14\/00577"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI17\/00524"],"award-info":[{"award-number":["PI17\/00524"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["RD16\/0011\/0024"],"award-info":[{"award-number":["RD16\/0011\/0024"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PIE14\/00061"],"award-info":[{"award-number":["PIE14\/00061"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Government of Catalonia","doi-asserted-by":"publisher","award":["2017-SGR-899"],"award-info":[{"award-number":["2017-SGR-899"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CERCA"},{"name":"Spanish Association Against Cancer"},{"name":"NTAP Cell Culture Initiative"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Reports"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.stemcr.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T23:23:11Z","timestamp":1548976991000},"page":"411-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas"],"prefix":"10.1016","volume":"12","author":[{"given":"Meritxell","family":"Carri\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Mazuelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Richaud-Patin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernat","family":"Gel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Terribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imma","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senda","family":"Jimenez-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Biayna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Vendredy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conxi","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Raya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-9857","authenticated-orcid":false,"given":"Eduard","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stemcr.2019.01.001_bib1","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1093\/hmg\/ddv103","article-title":"Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning","volume":"24","author":"Anastasaki","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.stemcr.2019.01.001_bib2","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1073\/pnas.1103509108","article-title":"Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors","volume":"108","author":"Ban","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.stemcr.2019.01.001_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/gcc.20921","article-title":"Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors","volume":"50","author":"Beert","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.stemcr.2019.01.001_bib4","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.stemcr.2017.03.007","article-title":"Melanoma-derived iPCCs show differential tumorigenicity and therapy response","volume":"8","author":"Bernhardt","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stemcr.2019.01.001_bib5","series-title":"Neurofibromatosis Type 1:Molecular and Cellular Biology","first-page":"549","article-title":"Cell of origin and the contribution of microenvironment in NF1 tumorigenesis and therapeutic implications","author":"Buchstaller","year":"2012"},{"key":"10.1016\/j.stemcr.2019.01.001_bib6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/humu.23552","article-title":"Analysis of intra-tumor heterogeneity in neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: correlating histological and genomic findings","volume":"39","author":"Carri\u00f3","year":"2018","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.stemcr.2019.01.001_bib7","doi-asserted-by":"crossref","first-page":"39348","DOI":"10.1038\/srep39348","article-title":"A\u00a0comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape","volume":"7","author":"Castellanos","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.stemcr.2019.01.001_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ccell.2014.09.009","article-title":"Cells of origin in the embryonic nerve roots for NF1-associated plexiform neurofibroma","volume":"26","author":"Chen","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.stemcr.2019.01.001_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1006\/bbrc.1997.6645","article-title":"Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene","volume":"234","author":"D\u00e4schner","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3 Pt 1","key":"10.1016\/j.stemcr.2019.01.001_bib10","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.stemcr.2019.01.001_bib11","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas","volume":"375","author":"Dombi","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stemcr.2019.01.001_bib12","first-page":"10","article-title":"Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency","volume":"4","author":"Ebrahimi","year":"2015","journal-title":"Cell Regen. (Lond)"},{"key":"10.1016\/j.stemcr.2019.01.001_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty-first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.stemcr.2019.01.001_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/humu.21387","article-title":"Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: importance of copy neutral LOH","volume":"32","author":"Garcia-Linares","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.stemcr.2019.01.001_bib15","doi-asserted-by":"crossref","first-page":"170045","DOI":"10.1038\/sdata.2017.45","article-title":"A high-throughput molecular data resource for cutaneous neurofibromas","volume":"4","author":"Gosline","year":"2017","journal-title":"Sci. Data"},{"key":"10.1016\/j.stemcr.2019.01.001_bib16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/neuonc\/noy013","article-title":"The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors","volume":"20","author":"Higham","year":"2018","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.stemcr.2019.01.001_bib17","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1158\/1078-0432.CCR-14-3049","article-title":"Whole exome sequencing reveals the order of genetic changes during malignant transformation and metastasis in a single patient with NF1-plexiform neurofibroma","volume":"21","author":"Hirbe","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.stemcr.2019.01.001_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrn1746","article-title":"The origin and development of glial cells in peripheral nerves","volume":"6","author":"Jessen","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.stemcr.2019.01.001_bib19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1128\/MCB.17.2.862","article-title":"Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase","volume":"17","author":"Kim","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.stemcr.2019.01.001_bib20","first-page":"325","article-title":"Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes","volume":"11","author":"Kim","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.stemcr.2019.01.001_bib21","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.celrep.2013.05.036","article-title":"An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression","volume":"3","author":"Kim","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.stemcr.2019.01.001_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.15252\/embj.201490736","article-title":"Reprogramming of human cancer cells to pluripotency for models of cancer progression","volume":"34","author":"Kim","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.stemcr.2019.01.001_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0165-4608(99)00006-0","article-title":"Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas","volume":"113","author":"Kluwe","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.stemcr.2019.01.001_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.stem.2017.01.009","article-title":"Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia","volume":"20","author":"Kotini","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2019.01.001_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.expneurol.2017.10.012","article-title":"Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening","volume":"299","author":"Kraniak","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.stemcr.2019.01.001_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00284658","article-title":"Cell culture studies on neurofibromatosis (von Recklinghausen). II. Occurrence of glial cells in primary cultures of peripheral neurofibromas","volume":"63","author":"Krone","year":"1983","journal-title":"Hum. Genet."},{"key":"10.1016\/j.stemcr.2019.01.001_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/pcmr.12369","article-title":"NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model","volume":"28","author":"Larribere","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.stemcr.2019.01.001_bib28","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/nbt1365","article-title":"Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells","volume":"25","author":"Lee","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stemcr.2019.01.001_bib29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nprot.2010.35","article-title":"Derivation of neural crest cells from human pluripotent stem cells","volume":"5","author":"Lee","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stemcr.2019.01.001_bib30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/labinvest.2016.88","article-title":"Immortalization of human normal and NF1 neurofibroma Schwann cells","volume":"96","author":"Li","year":"2016","journal-title":"Lab. Invest."},{"key":"10.1016\/j.stemcr.2019.01.001_bib31","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/humu.20389","article-title":"Comprehensive NF1 screening on cultured Schwann cells from neurofibromas","volume":"27","author":"Maertens","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.stemcr.2019.01.001_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1215\/15228517-2008-011","article-title":"Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1","volume":"10","author":"Mautner","year":"2008","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.stemcr.2019.01.001_bib33","first-page":"612","article-title":"Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases","volume":"11","author":"McCarron","year":"1998","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.stemcr.2019.01.001_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nprot.2012.156","article-title":"Directed differentiation of human pluripotent cells to neural crest stem cells","volume":"8","author":"Menendez","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.stemcr.2019.01.001_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/emmm.200900027","article-title":"Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene","volume":"1","author":"Miller","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.stemcr.2019.01.001_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9440(10)63992-2","article-title":"Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells","volume":"158","author":"Muir","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.stemcr.2019.01.001_bib37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/088307380201700816","article-title":"Therapy for plexiform neurofibromas in children with neurofibromatosis 1: an overview","volume":"17","author":"Packer","year":"2002","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.stemcr.2019.01.001_bib38","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.21873\/anticanres.11703","article-title":"Application of cancer cell reprogramming technology to human cancer research","volume":"37","author":"Pan","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.stemcr.2019.01.001_bib39","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nm.4238","article-title":"Patient-derived induced pluripotent stem cells in cancer research and precision oncology","volume":"22","author":"Papapetrou","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.stemcr.2019.01.001_bib40","first-page":"760","article-title":"Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis","volume":"59","author":"Peltonen","year":"1988","journal-title":"Lab. Invest."},{"key":"10.1016\/j.stemcr.2019.01.001_bib41","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1038\/onc.2016.464","article-title":"The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas","volume":"36","author":"Pemov","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.stemcr.2019.01.001_bib42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpeds.2011.08.051","article-title":"Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1","volume":"160","author":"Prada","year":"2012","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.stemcr.2019.01.001_bib43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/1098-2264(200008)28:4<425::AID-GCC8>3.0.CO;2-E","article-title":"Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1","volume":"28","author":"Rasmussen","year":"2000","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.stemcr.2019.01.001_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.stemcr.2019.01.001_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature08129","article-title":"Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells","volume":"460","author":"Raya","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2019.01.001_bib46","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1471-4159.2009.06498.x","article-title":"Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells","volume":"112","author":"Reiprich","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.stemcr.2019.01.001_bib47","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1242\/dev.121.11.3583","article-title":"Neurofibromin-deficient fibroblasts fail to form perineurium in\u00a0vitro","volume":"121","author":"Rosenbaum","year":"1995","journal-title":"Development"},{"key":"10.1016\/j.stemcr.2019.01.001_bib48","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","article-title":"Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations","volume":"9","author":"Serra","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.stemcr.2019.01.001_bib49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/90148","article-title":"Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas","volume":"28","author":"Serra","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.stemcr.2019.01.001_bib50","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/jid.2008.274","article-title":"Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas","volume":"129","author":"Steinmann","year":"2009","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.stemcr.2019.01.001_bib51","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.stemcr.2019.01.001_bib52","series-title":"Neurofibromatosis: Phenotype, Natural History, and Pathogenesis","author":"VM","year":"1992"},{"key":"10.1016\/j.stemcr.2019.01.001_bib53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<117::AID-GCC1>3.0.CO;2-H","article-title":"Culture of cytogenetically abnormal Schwann cells from benign and malignant NF1 tumors","volume":"27","author":"Wallace","year":"2000","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.stemcr.2019.01.001_bib54","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.expneurol.2017.04.001","article-title":"Human stem cell modeling in neurofibromatosis type 1 (NF1)","volume":"299","author":"Wegscheid","year":"2018","journal-title":"Exp. Neurol."}],"updated-by":[{"DOI":"10.1016\/j.stemcr.2019.02.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000}}],"container-title":["Stem Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671119300025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671119300025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T02:11:18Z","timestamp":1662862278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213671119300025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2213671119300025"],"URL":"https:\/\/doi.org\/10.1016\/j.stemcr.2019.01.001","relation":{},"ISSN":["2213-6711"],"issn-type":[{"value":"2213-6711","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stemcr.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}